Substance / Medication

Cefditoren pivoxil

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

1
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy and safety of cefditoren pivoxil for exacerbations of chronic obstructive pulmonary disease: A prospective multicenter interventional study.
Miyazaki Taiga, Fukushima Kiyoyasu, Hashiguchi Kohji et al. · J Infect Chemother · 2019
PMID: 30982729Observational
Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.
Sadahira Takuya, Wada Koichiro, Araki Motoo et al. · J Antimicrob Chemother · 2017
PMID: 27733519Observational
[A multicenter study of 7-day cefditoren pivoxil treatment for group A streptococcal infection].
Sakata Hiroshi · Jpn J Antibiot · 2007
PMID: 18198654Observational
Changes in surface properties by granulation and physicochemical stability of granulated amorphous cefditoren pivoxil with additives.
Yokoi Yukiko, Yonemochi Etsuo, Terada Katsuhide · Int J Pharm · 2004
PMID: 15265548Observational
[Efficacy and safety of cefditoren pivoxil in treatment of respiratory infections, a clinical study].
Li Jia-Tai, Gao Lei, Xue Feng et al. · Zhonghua Yi Xue Za Zhi · 2003
PMID: 12820915Observational
Kounis syndrome induced by cefditoren pivoxil.
Barbarroja-Escudero J, Sánchez-González M J, Antolín-Amérigo D et al. · Int J Cardiol · 2016
PMID: 26800128Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Cefditoren pivoxil (substance)
SNOMED CT
370399008
UMLS CUI
C0245519

Clinical Data

This intervention maps to 9 entities in the Healos knowledge graph.

9
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.